News

Modalis Therapeutics to Present at the ASGCT Annual Meeting

News 2022/04/20

Modalis Therapeutics to Present Data Supporting of Development of Transformative Epigenetic Modulating Medicines for the Treatment of a Type of Muscular Dystrophy and the Other Genetic Disorders at the ASGCT Annual Meeting

 

Please see the link for details

Modalis Therapeutics to Present Data Supporting of Development of Transformative Epigenetic Modulating Medicines at the ASGCT Annual Meeting